Curated News: National Institutes of Health (NIH)

Filters close
1-Feb-2021 9:30 AM EST
Stem Cell Study Illuminates the Cause of a Devastating Inherited Heart Disorder
Perelman School of Medicine at the University of Pennsylvania

Stem cell study findings show that LMNA gene mutations can disrupt the “identity” of heart muscle cells

Released: 29-Jan-2021 10:15 AM EST
Noninvasive blood test tracks organ injury from COVID-19
Cornell University

A Cornell-led collaboration has developed a noninvasive blood test that uses cell-free DNA to gauge the damage that COVID-19 inflicts on cells, tissues and organs, and could help aid in the development of new therapies.

Released: 29-Jan-2021 9:55 AM EST
ASCB announces its inaugural cohort of NIH MOSAIC Scholars
American Society for Cell Biology (ASCB)

The American Society for Cell Biology (ASCB) is pleased to announce its first cohort of scholars for the Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) K99/R00 program, an initiative funded by the National Institutes of Health.

Released: 29-Jan-2021 8:00 AM EST
Immune System Sets ‘Tripwire’ to Protect against Viruses
University of California San Diego

A new study by UC San Diego biologists has revealed insights on the intricate, adaptive mechanisms of a protective system employed by the cells of mammalian immune systems. These defenses have evolved to set a type of tripwire that produces an immune response against attack from viruses.

25-Jan-2021 4:10 PM EST
Researchers use patients’ cells to test gene therapy for rare eye disease
NIH, National Eye Institute (NEI)

Scientists at the National Eye Institute (NEI) have developed a promising gene therapy strategy for a rare disease that causes severe vision loss in childhood. A form of Leber congenital amaurosis, the disease is caused by autosomal-dominant mutations in the CRX gene, which are challenging to treat with gene therapy.

Released: 27-Jan-2021 12:50 PM EST
New study points to better diagnostics for cancer
University of California, Irvine

A new University of California, Irvine-led study finds a new method for identifying biomarkers may aid in early cancer diagnosis. The study focused on lung cancer, however the Cell Heterogeneity-Adjusted cLonal Methylation (CHALM) method has been tested on aging and Alzheimer’s diseases as well and is expected to be effective for studying other diseases.

Released: 26-Jan-2021 2:40 PM EST
Two Anti-viral Enzymes Transform Pre-Leukemia Stem Cells into Leukemia
UC San Diego Health

Viral infections and space travel similarly trigger inflammation and the enzymes APOBEC3C and ADAR1; UC San Diego researchers are developing ways to inhibit them as a means to potentially lower cancer risk for both astronauts and people on Earth.

Released: 26-Jan-2021 12:55 PM EST
Race Plays a Role in Children’s Food Allergies
RUSH

Black children have significantly higher rates of shellfish and fish allergies than white children, confirming that race plays an important role in how children are affected by food allergies, researchers at Rush University Medical Center have found.

Released: 26-Jan-2021 12:35 PM EST
Using candy to sniff out probable cases of COVID-19
Ohio State University

Scientists have proposed that using a cheap and simple product – hard candy – to screen for the loss of taste and smell in populations at risk for COVID-19 exposure may help detect probable positive cases in otherwise asymptomatic people.

Released: 26-Jan-2021 11:40 AM EST
Wayne State secures more than $5 million in NIH funding for cerebral palsy research
Wayne State University Division of Research

The National Institutes of Health is supporting a Wayne State University School of Medicine physician-researcher’s work at preventing and treating cerebral palsy in the form of two new five-year R01 grants worth a collective $5.59 million.

25-Jan-2021 12:50 PM EST
Iron-Carrying Extracellular Vesicles are Key to Respiratory Viral-Bacterial Coinfection
Health Sciences at the University of Pittsburgh

The finding can offer a new way for creating therapies to prevent secondary bacterial infections.

Released: 25-Jan-2021 11:05 AM EST
Recruiting Starts at University of Miami Health System for NIH Study of COVID-19 Immunity
University of Miami Health System, Miller School of Medicine

The University of Miami Health System is one of five sites nationally and the only one in the Southeast U.S. chosen to participate in a National Institute of Allergy and Infectious Diseases (NIAID) study looking at people who have had COVID-19 or have had a COVID-19 vaccine to examine the durability and robustness of participants’ antibody and T-cell responses to the virus.

Released: 22-Jan-2021 2:35 PM EST
NIH-funded study examines mono, chronic fatigue syndrome in college students
DePaul University

A longitudinal study from DePaul University and Northwestern University followed 4,501 college students to examine risk factors that may trigger longer illness.

Released: 22-Jan-2021 8:25 AM EST
Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk, Population Study Reveals
Perelman School of Medicine at the University of Pennsylvania

Several genetic mutations previously linked to breast cancer and included on commercial genetic tests, including direct-to-consumer tests, were found not to increase a woman’s risk of disease, according to a population study of more than 64,000 women published online today in the New England Journal of Medicine from several institutions, including Penn Medicine.

Released: 21-Jan-2021 2:05 PM EST
New antibody therapies found to potentially fight COVID-19
University of Texas Health Science Center at Houston

Researchers at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications.

   
Released: 21-Jan-2021 12:00 PM EST
ARVO Foundation Announces 2021 Mallinckrodt Uveitis Research Fellowship Recipient
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Mallinckrodt Uveitis Research Fellowship, generously funded by Mallinckrodt Pharmaceuticals. The award, funded through the ARVO Foundation, supports an early career investigator with a one-year grant of $45,000 to study an aspect of uveitis or other inflammatory conditions of the eye. The 2021 awardee is Shilpa Kodati, MD of the National Eye Institute (NEI) at the National Institutes of Health (NIH).

   
Released: 21-Jan-2021 11:35 AM EST
Wistar Scientists Make Pivotal Discovery on the Mechanism of Epstein-Barr Virus Latent Infection
Wistar Institute

Wistar researchers have discovered a new enzymatic function of the Epstein-Barr Virus (EBV) protein EBNA1, a critical factor in EBV’s ability to transform human cells and cause cancer. Published in Cell, this study provides new indications for inhibiting EBNA1 function, opening up fresh avenues for development of therapies to treat EBV-associated cancers.

18-Jan-2021 8:05 PM EST
Patients in Cancer Remission at High Risk for Severe COVID-19 Illness
Perelman School of Medicine at the University of Pennsylvania

Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, a new study from Penn Medicine published online today in JNCI Cancer Spectrum shows.

19-Jan-2021 4:30 PM EST
Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice
UC San Diego Health

UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.

Released: 20-Jan-2021 10:00 AM EST
Reviving Exhausted Immune Cells to Fight Cancer
UT Southwestern Medical Center

DALLAS – Jan. 19, 2021 – Eliminating a single gene can turn exhausted cancer-fighting immune cells known as CD8+ T cells back into refreshed soldiers that can continue to battle malignant tumors, a new study led by UT Southwestern researchers suggests. The findings, published online this week in the Journal for Immunotherapy of Cancer, could offer a new way to harness the body’s immune system to attack cancers.

Released: 19-Jan-2021 3:05 PM EST
Unlocking 'the shape of water' in mechanisms of antibiotic resistance
University of Illinois Chicago

Researchers captured and comparted hi-res images of ribosome structures from sensitive and resistant bacteria and report that a water molecule needed for antibiotic binding was not present in the ribosomes from the drug-resistant bugs.

   
Released: 19-Jan-2021 11:30 AM EST
NAU-TGen study results show COVID-19 virus triggers antibodies from previous coronavirus infections
Northern Arizona University

A collaborative study shows COVID-19 virus triggers antibodies from previous coronavirus infections, such as the common cold. It may also explain how previous exposure could partially account for differences in severity between old vs. young patients

Released: 19-Jan-2021 3:05 AM EST
Alzheimer's microbe hypothesis gets major NIH funding
MCI 911

After years of paltry funding, research on the possible role of microbes in the causation of Alzheimer's disease will now get a major infusion of grants from the NIH's National Institute on Aging

Released: 18-Jan-2021 5:05 PM EST
FLCCC Alliance issues public response to new NIH recommendation on the use of ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

The Front Line COVID-19 Critical Care Alliance (FLCCC) has issued a public response to the National Institutes of Health (NIH) regarding the NIH COVID-19 Treatment Guidelines Panel’s “neither for nor against” recommendation for the use of ivermectin in the treatment of COVID-19.

15-Jan-2021 3:50 PM EST
New computational tool reliably differentiates between cancer and normal cells from single-cell RNA-sequencing data
University of Texas MD Anderson Cancer Center

MD Anderson researchers have developed a new computational tool to accurately differentiate between cancer cells and normal cells when analyzing large single-cell RNA-sequencing data.

Released: 15-Jan-2021 1:35 PM EST
Johns Hopkins School of Nursing Ranked No. 1 in NIH Funding
Johns Hopkins School of Nursing

The Johns Hopkins School of Nursing (JHSON) is ranked No. 1 among schools of nursing for total funding received from the National Institutes of Health (NIH) for fiscal year 2020. Its grants range in topics from health equity, resilience, gender norms, aging, cardiovascular health, health of Indigenous people, HIV, trauma, violence, and more.

Released: 15-Jan-2021 12:20 PM EST
Target Discovered That Halts Osteoarthritis-Like Knee Cartilage Degeneration
Perelman School of Medicine at the University of Pennsylvania

In a mouse study, researchers used nanotechnology and previous knowledge of a protein pathway to significantly reduce knee cartilage degeneration and pain

Released: 15-Jan-2021 9:45 AM EST
CHOP Researchers Find NTRK Fusions More Common than Expected in Pediatric Tumors
Children's Hospital of Philadelphia

In a large study of pediatric cancer patients, researchers from Children’s Hospital of Philadelphia (CHOP) have analyzed the frequency, fusion partners, and clinical outcome of neurotrophic tyrosine receptor kinase (NTRK) fusions, which are clinical biomarkers that identify patients suitable for treatment with FDA-approved TRK inhibitors. The researchers found that NTRK fusions are more common in pediatric tumors and also involve a wider range of tumors than adult cancers, information that could help prioritize screening for NTRK fusions in pediatric cancer patients who might benefit from treatment with TRK inhibitors.

Released: 14-Jan-2021 12:10 PM EST
Reverse engineering 3D chromosome models for individual cells
University of Illinois Chicago

A new computational technique that uses heat map data to reverse engineer highly detailed models of chromosomes. Through this work, researchers have uncovered new information about the close spatial relationships that chromatin folding creates between genes that can be highly distant from one another along DNA strands.

   
Released: 14-Jan-2021 9:00 AM EST
Moffitt Researchers Discover Biochemical Pathway That Protects Cells from Ferroptosis Cell Death
Moffitt Cancer Center

In an article published in Cell Metabolism, Moffitt Cancer Center researchers report on a newly discovered biochemical pathway that protects cells from a type of cell death called ferroptosis.

Released: 13-Jan-2021 2:10 PM EST
New Insights Into the Control of Inflammation
Wistar Institute

Wistar scientists discovered that EGR1 inhibits expression of pro-inflammatory genes in macrophages. The discovery expands the understanding of how macrophages are set off and deactivated in the inflammatory process, which is critical in many normal and pathological conditions.

Released: 13-Jan-2021 11:35 AM EST
Researcher Developing Scoring System to Redefine How U.S. Patients are Prioritized for Liver Transplant
University of Miami Health System, Miller School of Medicine

Researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are collaborating with faculty at the University of Pennsylvania to develop a risk score that more comprehensively prioritizes liver cancer patients for transplantation.

Released: 12-Jan-2021 9:00 AM EST
UTSW Researchers Identify New Gene Involved in Breast Cancer Growth
UT Southwestern Medical Center

DALLAS – Jan. 12, 2021 – A team of UT Southwestern researchers has identified a gene involved in the growth of breast cancer, a finding that could lead to potential new targets for treatment.

8-Jan-2021 9:55 AM EST
Nurse Involvement Promotes Discussion of Advanced Care Planning During Office Visits
Atrium Health Wake Forest Baptist

Most doctors would agree that advanced care planning (ACP) for patients, especially older adults, is important in providing the best and most appropriate health care over the course of a patient’s life.

6-Jan-2021 11:30 AM EST
New Statistical Method Exponentially Increases Ability to Discover Genetic Insights
Perelman School of Medicine at the University of Pennsylvania

A test of the Sum-Share statistical method using only summary-level data found 1,734 genetic variations associated with cardiovascular-related conditions when just one had previously been likely

Released: 6-Jan-2021 5:35 PM EST
Study identifies repurposed drug with potential to protect hearing
Creighton University

An FDA-approved drug that is currently used in treating cancers has the potential to protect against or treat hearing loss in humans.

Released: 6-Jan-2021 2:50 PM EST
Wait for Me: Cell Biologists Decipher Signal that Ensures No Chromosome is Left Behind
University of California San Diego

Biologists have unraveled the mystery of how chromosomes are inherited correctly every time a cell divides. They discovered how a “matchmaker” molecule stops cell division until components are ready to be split. Alterations in the process can result in birth defects and certain cancers.

Released: 6-Jan-2021 2:30 PM EST
Mouse Study Finds Link Between Gut Disease and Brain Injury in Premature Infants
Johns Hopkins Medicine

Physicians have long known that necrotizing enterocolitis (NEC), a potentially lethal inflammatory condition that destroys a premature infant’s intestinal lining, is often connected to the development of severe brain injury in those infants who survive. However, the means by which the diseased intestine “communicates” its devastation to the newborn brain has remained largely unknown.

Released: 6-Jan-2021 11:30 AM EST
Advancing The Study of T Cells to Improve Immunotherapy
UT Southwestern Medical Center

DALLAS – Jan. 6, 2020 – UT Southwestern scientists have developed a new method to study the molecular characteristics of T cells, critical immune cells that recognize and attack invaders in the body such as viruses, bacteria, and cancer.

4-Jan-2021 9:50 AM EST
Immunology study finds protein critical to T cell metabolism and anti-tumor immune response
University of Texas MD Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have discovered that a protein called NF-kappa B-inducing kinase (NIK) is essential for the shift in metabolic activity that occurs with T cell activation, making it a critical factor in regulating the anti-tumor immune response.

Released: 4-Jan-2021 10:40 AM EST
Nanoparticle drug-delivery system developed to treat brain disorders
Brigham and Women’s Hospital

Use of the delivery system in mouse models results in unprecedented siRNA penetration across the intact blood brain barrier

Released: 4-Jan-2021 8:10 AM EST
Monell Center/Temple University Team Receive NIH Funding for Non-traditional Technologies to Fight COVID-19
Monell Chemical Senses Center

A Monell Chemical Senses Center and Temple University team recently became part of a new, multi-institute National Institute of Health (NIH)-funded initiative called the Rapid Acceleration of Diagnostic Radical program (RADx). The NIH invested $107 million at 43 institutions across the country to support non-traditional and repurposed technologies to combat the pandemic and address future viral disease outbreaks.

Released: 30-Dec-2020 2:35 PM EST
Cedars-Sinai Neuroscientists Awarded Prestigious NIH Grant
Cedars-Sinai

Ueli Rutishauser, PhD, professor of Neurosurgery, Neurology and Biomedical Sciences at Cedars-Sinai, has dedicated his career to understanding how new memories are formed and stored in the brain. His latest work, involving the recording of patients' single neurons, landed him and a multidisciplinary team of scientists a five-year, $8 million total research grant.

Released: 29-Dec-2020 11:40 AM EST
UCLA scientists develop high-throughput mitochondria transfer device
University of California, Los Angeles (UCLA), Health Sciences

Scientists from the UCLA Jonsson Comprehensive Cancer Center have developed a simple, high-throughput method for transferring isolated mitochondria and their associated mitochondrial DNA into mammalian cells. This approach enables researchers to tailor a key genetic component of cells, to study and potentially treat debilitating diseases such as cancer, diabetes and metabolic disorders.

Released: 22-Dec-2020 10:15 AM EST
Cormac the Llama Yields Antibodies that may Prove Effective Against COVID-19 Infection
Uniformed Services University of the Health Sciences (USU)

Researchers from the Uniformed Services University (USU) recently identified pint-sized antibodies, or “nanobodies,” that could protect against COVID-19. At least one of these nanobodies – produced by a llama named Cormac – also appears to work well in either liquid or aerosol form, suggesting it could also help protect a person’s lungs from infections.

Released: 21-Dec-2020 12:15 PM EST
Digging Deep For Differences In Duchenne Muscular Dystrophy
UT Southwestern Medical Center

DALLAS – Dec. 21, 2020 – A UT Southwestern research team has catalogued gene activity in the skeletal muscle of mice, comparing healthy animals to those carrying a genetic mutation that causes Duchene muscular dystrophy (DMD) in humans. The findings, published online recently in PNAS, could lead to new treatments for this devastating degenerative disease and insights into factors that affect muscle development.

Released: 18-Dec-2020 3:15 PM EST
$2.9 million NIH grant will help IU researcher expand work on subconcussive impacts
Indiana University

Every year, nearly 2.5 million U.S. high school athletes participate in contact sports. Each of these athletes sustains an average of 650 subconcussive head impacts in a single season, hits that can negatively affect brain health.

Released: 18-Dec-2020 12:55 PM EST
Scientists get the most realistic view yet of a coronavirus spike’s protein structure
SLAC National Accelerator Laboratory

The first detailed images of coronavirus spikes in their natural state, while still attached to the virus and without using chemical fixatives that might distort their shape, provide quicker, more realistic snapshots of the infection apparatus.



close
2.48378